| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/27/2005 | EP1557462A2 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 07/27/2005 | EP1557432A2 Hybrid proteins which form heterodimers |
| 07/27/2005 | EP1557431A1 Assay and reagents for quantifying hBNP |
| 07/27/2005 | EP1557430A1 Antibody and utilization of the same |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557178A1 Use of sglt homolog |
| 07/27/2005 | EP1557173A1 Soluble CTLA4 mutant molecules and uses thereof |
| 07/27/2005 | EP1556698A1 Elisa kits for detecting collagenase 3 as a proenzyme and in an activated form in body fluids and cell culture supernatants |
| 07/27/2005 | EP1556508A2 Antibodies and methods for generating genetically altered antibodies with high affinity |
| 07/27/2005 | EP1556499A2 Monoclonal antibodies specific for cariogenic bacteria |
| 07/27/2005 | EP1556487A2 Transplantable cell |
| 07/27/2005 | EP1556403A2 Multimeric protein engineering |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556084A2 Methods of regulating body weight |
| 07/27/2005 | EP1556083A2 Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same |
| 07/27/2005 | EP1556071A2 Methods to prevent tumor recurrence by blockade of tgf-beta |
| 07/27/2005 | EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods |
| 07/27/2005 | EP0990000B1 Connective tissue growth factor-3 |
| 07/27/2005 | EP0935754B1 Compositions and methods for detection of antibody binding to cells |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | EP0682707B1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 07/27/2005 | CN1647506A 数码相机 Digital Camera |
| 07/27/2005 | CN1646916A Compositions, methods and kits for immunochemical determination of mannan-binding lectin (MBL) |
| 07/27/2005 | CN1646910A Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor |
| 07/27/2005 | CN1646692A Genetic products differentially expressed in tumors and use thereof |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646567A Anti-idiotype anti-CEA antibody molecules and its use as cancer vaccine |
| 07/27/2005 | CN1646566A Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| 07/27/2005 | CN1646565A IgY production for preventing oral cavity disease and tooth paste based on it |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646561A Gene conferring resistance to phytophthora infestans (late-blight) in solanacea |
| 07/27/2005 | CN1646163A Administration of agents for the treatment of inflammation |
| 07/27/2005 | CN1646162A Use of an inhibitor or antagonist against tissue factor |
| 07/27/2005 | CN1646161A Reagents and treatment methods for autoimmune diseases |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1645145A Method and reagent box for inspecting mycelian protein antibody of white candida |
| 07/27/2005 | CN1644708A Mycobacterium tuberculosis superoxide dismutase |
| 07/27/2005 | CN1644693A Protein having tpo activity |
| 07/27/2005 | CN1644685A Monoclone antibody against human cardiac troponin I and its use |
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212334C Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use |
| 07/27/2005 | CN1212155C CD 40 binding molecules and CTL peptides for treating tumors |
| 07/27/2005 | CN1212152C Tumor necrosis factor antagonists and their use in endometriosis |
| 07/27/2005 | CA2555509A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer |
| 07/26/2005 | US6921846 Preparing immunoglobulin for in vitro and in vivo clinical diagnostics of immune system defects; immunotherapy |
| 07/26/2005 | US6921809 Immunoglobulin conjugate comprising amino acid sequences from dihydrolipoamide dehydrogenase (P64K) for use as tool in immunodetection of heterologous protein expression; vaccine development |
| 07/26/2005 | US6921646 DNA sequence comprising signal tranduction protein for monitoring cell regulation and morphological/embryonic development; drug screening |
| 07/26/2005 | US6921645 Antibodies to chemokine β-4 |
| 07/26/2005 | US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 07/26/2005 | US6921537 Extracting with a polyoxyethylene detergent to deplete inner membranes, extracting remaining outer membranes with zwitterionic betaine dertergent to separate lipooligosaccharides from insoluble factions used for vaccines |
| 07/26/2005 | US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain |
| 07/26/2005 | CA2373422C Protein nectin-3 |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2240097C Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 07/26/2005 | CA2235131C A method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |
| 07/26/2005 | CA2174632C Methods of screening for beta-amyloid peptide production inhibitors |
| 07/26/2005 | CA2143823C Retro-, inverso - and retro-inverso synthetic peptide analogues |
| 07/26/2005 | CA2076961C Igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use |
| 07/21/2005 | WO2005066867A2 Modulators of cell-surface receptors of the ig-class |
| 07/21/2005 | WO2005066365A1 Specific expression of ndrg2 gene in dendritic cells and detection of dendritic cells |
| 07/21/2005 | WO2005066363A2 Cancer specific gene ccndbp1 |
| 07/21/2005 | WO2005066348A2 Interleukin-12 targeted to oncofoetal fibronectin |
| 07/21/2005 | WO2005066211A2 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention |
| 07/21/2005 | WO2005066210A2 Compositions and methods for treating t-cell mediated autoimmune diseases |
| 07/21/2005 | WO2005065710A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 07/21/2005 | WO2005065328A2 Macrophage migration inhibitory factor (mif) as marker for urological inflammatory disease |
| 07/21/2005 | WO2005065121A2 Methods and compositions for the production of monoclonal antibodies |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2005037866A3 Igg3 anti rhesus-d in the line yb2/0 having a high phagocytosis activity |
| 07/21/2005 | WO2005037228A3 Halogen phosphonate monoesters |
| 07/21/2005 | WO2005030251A8 Compositions and methods to accelerate hematologic recovery |
| 07/21/2005 | WO2005028513A3 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 07/21/2005 | WO2005025618A3 Treatment of rheumatoid arthritis with cd99 antagonists |
| 07/21/2005 | WO2005012351A3 Novel functions for decay accelerating factor (daf) in inflammation |
| 07/21/2005 | WO2005011607A3 Treatment of cancers expressing p95 erbb2 |
| 07/21/2005 | WO2004090109A3 Ccn3 compositions and methods |
| 07/21/2005 | WO2004056866A8 Asthma susceptibility locus |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050159591 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050159590 Variants of interleukin-1 receptor antagonist: compositions and uses thereof |
| 07/21/2005 | US20050159588 Nucleotide sequences coding tumor-associated antigenic target polypeptides; diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 07/21/2005 | US20050159587 Extracellular junctional adhesion molecules |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050159357 Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050158830 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/21/2005 | US20050158829 Fusion polypeptides capable of activating receptors |
| 07/21/2005 | US20050158828 Preparing immunoglobulin dimer for use in prevention and treatment of B cell lymphoma and chronic lymphocytic leukemia; immunotherapeutics |
| 07/21/2005 | US20050158826 Using tumor necrosis factor receptor releasing enzyme as therapeutic tool in treatment of inflammation, arthritis, rheumatoid arthritis and multiple sclerosis |
| 07/21/2005 | US20050158825 Using fungal host as bioreactor for production of monoclonal antibodies |
| 07/21/2005 | US20050158823 Using tumor necrosis factor related apoptosis inducing ligand (TRAIL) as tool in tissue targeted treatment of cancer cells |
| 07/21/2005 | US20050158810 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 07/21/2005 | US20050158803 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing |
| 07/21/2005 | US20050158799 TRIF-related adaptor molecule (TRAM) and uses thereof |
| 07/21/2005 | US20050158796 Use of a tag to enrich polypeptides libraries |
| 07/21/2005 | US20050158795 Antibody and use thereof |
| 07/21/2005 | US20050158793 Immunoassays |
| 07/21/2005 | US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
| 07/21/2005 | US20050158778 Transcription factor for use in generating immoglobulin for prevention and treatment of fungal infection |